A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.
A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.
复制标题
DOI:
10.1016/j.cell.2010.02.027
复制
发表时间:
2010-04-02
期刊:
影响因子:
64.5
通讯作者:
Settleman J
中科院分区:
文献类型:
--
作者:
Sharma SV;Lee DY;Li B;Quinlan MP;Takahashi F;Maheswaran S;McDermott U;Azizian N;Zou L;Fischbach MA;Wong KK;Brandstetter K;Wittner B;Ramaswamy S;Classon M;Settleman J
Accumulating evidence implicates heterogeneity within cancer cell populations in the response to stressful exposures, including drug treatments. While modeling the acute response to various anti-cancer agents in drug-sensitive human tumor cell lines, we consistently detected a small subpopulation of reversibly “drug-tolerant” cells. These cells demonstrate >100-fold reduced drug sensitivity, and maintain viability via engagement of IGF-1 receptor signaling and an altered chromatin state that requires the histone demethylase RBP2/KDM5A/Jarid1A. This drug-tolerant phenotype is transiently acquired and relinquished at low frequency by individual cells within the population, implicating the dynamic regulation of phenotypic heterogeneity in drug tolerance. The drug-tolerant subpopulation can be selectively ablated by treatment with IGF-1 receptor inhibitors or chromatin-modifying agents, potentially yielding a therapeutic opportunity. Together, these findings suggest that cancer cell populations employ a dynamic survival strategy in which individual cells transiently assume a reversibly drug-tolerant state to protect the population from eradication by potentially lethal exposures.
登录
查看更多内容
影响因子:
8.8
作者:
通讯作者:
--
影响因子:
64.5
作者:
Klose, Robert J.;Yan, Qin;Kaelin, William G., Jr.
通讯作者:
Kaelin, William G., Jr.
影响因子:
5.3
作者:
Ahmed, S;Palermo, C;Walworth, NC
通讯作者:
Walworth, NC
影响因子:
64.8
作者:
Chang, Hannah H.;Hemberg, Martin;Huang, Sui
通讯作者:
Huang, Sui
影响因子:
64.5
作者:
Christensen, Jesper;Agger, Karl;Helin, Kristian
通讯作者:
Helin, Kristian